Agape ATP partners with Formedic to launch LEGA respiratory care device

Agape ATP Corp

Collaboration agreement signed Sept 25, 2024, to introduce LEGA, an electronic chest percussion device for airway clearance.
LEGA assists patients with COPD, pneumonia, bronchiectasis; close to 2,000 units already used in major hospitals in Malaysia and globally.
Respiratory care market estimated at USD 25.95 billion in 2024, projected to reach USD 49.84 billion by 2031.
Partnership expands ATPC into healthcare technology, diversifying its wellness portfolio with a proven medical device.
Joint R&D and marketing strategies to target hospitals, rehabilitation centers, and home users globally.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.